FDA Inspection
AstraZeneca ABAstraZeneca AB – FDA Inspection, Aug 30, 2019
Record Details
This FDA Inspection record concerns AstraZeneca AB, with an inspection on August 30, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 1e316cfa-44e5-4865-a427-6d8cb438e287
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1102604
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of AstraZeneca AB
7| Date | Classification | Office | Project area |
|---|---|---|---|
| December 1, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 11, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 7, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 26, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 29, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AstraZeneca AB
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.